Abstract:
The advent of effective agents for the treatment of osteoporosis has led to the view that placebo-controlled trials to test new agents for efficacy are no longer appropriate since proven treatments are available. In this review we argue that, if new agents are to be developed, there is still a place for the placebo-controlled trial. A move to studies of equivalence or non-inferiority raises more problems than it resolves.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 19 December 2001 / Accepted: 11 March 2002
Rights and permissions
About this article
Cite this article
Kanis, J., Oden, A., Johnell, O. et al. Uncertain Future of Trials in Osteoporosis. Osteoporos Int 13, 443–449 (2002). https://doi.org/10.1007/s001980200052
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001980200052